1. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection Abstract Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections. Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months. All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection. Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure. Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant to other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment. There is no significant difference in the use of acrylic lenses and silicon lens in our results. Gonçalves CA..; Garcia, Marcos A..; Odloak CM. ;Campos, Paloma C.; Boro, Luiz Humberto T.; Miyamoto, Daniela A.; Going, Mayalu C. Retina Sector- Department of Ophthalmology Ana Costa Hospital of Santos - HAC REFERENCES 1. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic macular edema. Five randomized trials. Am Intraocular Implant Soc S J. 1999;11:380-5. 2. Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macullar edema after posterior chamber lens implantation. Arch Ophthalmol. 1988;106(6):740-4. 3. Irvine SR. Cystoid maculopathy. Surv Ophthalmol. 1976;21:1-17. 4. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119:1380-3.. nAGEEYERACESEXBCVA BEFOREBCVA AFTERDISEASESLIO TREATMENT 1`78 ODWHITEMALE20/8020/20DMACRYLIC 265 OEWHITEFEMALE20/10020/30NONESILICON 369 AOWHITEFEMALE20/60 - 20/6020/25 - 20/20DMACRYLIC 472 OEWHITEMALE20/8020/20NONEACRYLIC 581 OEWHITEMALE20/7020/25DMACRYLIC 670 ODWHITEMALE20/6020/25NONESILICON 769 OEWHITEFEMALE20/7020/30NONESILICON 880 ODWHITEMALE20/8020/20NONESILICON 950 ODWHITEMALE20/6020/20NONEACRYLIC

2. Gonçalves CA.; Garcia,MA.; Odloak CM. ; Campos, PC.; Boro, LHT.; Miyamoto, DA.; Going, MC. Retina Sector- Department of Ophthalmology Ana Costa Hospital of Santos – HAC There is no financial interest by the author and coauthor’s in this poster issue. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

3. Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

4. Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months. All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

5. Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure. There is no significant difference in the use of acrylic lenses and silicon lens in our result Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

6. Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant to other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

9. nAGEEYERACESEXBCVA BEFOREBCVA AFTERDISEASESLIO TREATMENT 1`78 ODWHITEMALE20/8020/20DMACRYLIC 265 OEWHITEFEMALE20/10020/30NONESILICON 369 AOWHITEFEMALE20/60 - 20/6020/25 - 20/20DMACRYLIC 472 OEWHITEMALE20/8020/20NONEACRYLIC 581 OEWHITEMALE20/7020/25DMACRYLIC 670 ODWHITEMALE20/6020/25NONESILICON 769 OEWHITEFEMALE20/7020/30NONESILICON 880 ODWHITEMALE20/8020/20NONESILICON 950 ODWHITEMALE20/6020/20NONEACRYLIC Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection